Mechanical testing methods for drug‐releasing vaginal rings

&NA; Vaginal rings (VRs) are currently marketed for contraceptive or hormone regulation purposes, and investigationally, have been widely reported for delivery of antiretrovirals to reduce HIV transmission. To date, there is no national or international standard for the mechanical testing and minimum performance characteristics of any VR based products. Here, we describe a series of mechanical tests examining the durometer hardness, static and dynamic compression response, tensile properties and twist resistance of vaginal rings. The tests were conducted on currently marketed VRs and a number of the International Partnership for Microbicides' (IPM) investigational VR formulations. With wider application in the field, the tests described herein could form the basis for a more standardised approach to the mechanical testing of VRs. Graphical abstract Figure. No caption available.

[1]  M. Walters,et al.  Urogynecology and Reconstructive Pelvic Surgery , 2006 .

[2]  J. Zeman,et al.  quantitative evaluation of by , 2010 .

[3]  A. Kemper,et al.  Dynamic material properties of the pregnant human uterus. , 2012, Journal of biomechanics.

[4]  H. Tibbals,et al.  Biomechanical properties of the vaginal wall: effect of pregnancy, elastic fiber deficiency, and pelvic organ prolapse. , 2008, American journal of obstetrics and gynecology.

[5]  J. Conrad,et al.  Passive stretch relationships in human uterine muscle. , 1966, American journal of obstetrics and gynecology.

[6]  Justin T. Clark,et al.  Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Clare F. McCoy,et al.  Controlling levonorgestrel binding and release in a multi-purpose prevention technology vaginal ring device. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[8]  Clare F. McCoy,et al.  Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel. , 2016, International journal of pharmaceutics.

[9]  D. Friend Intravaginal rings: controlled release systems for contraception and prevention of transmission of sexually transmitted infections , 2011, Drug Delivery and Translational Research.

[10]  M. Kammal,et al.  Mechanical properties of pelvic soft tissue of young women and impact of aging , 2014, International Urogynecology Journal.

[11]  Clare F. McCoy,et al.  A silicone elastomer vaginal ring for HIV prevention containing two microbicides with different mechanisms of action. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  N. Shelke,et al.  Engineering a Segmented Dual-Reservoir Polyurethane Intravaginal Ring for Simultaneous Prevention of HIV Transmission and Unwanted Pregnancy , 2014, PloS one.

[13]  A. Gettie,et al.  A novel intravaginal ring to prevent HIV-1, HSV-2, HPV, and unintended pregnancy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[14]  G. Doncel,et al.  A 90-Day Tenofovir Reservoir Intravaginal Ring for Mucosal HIV Prophylaxis , 2012, Antimicrobial Agents and Chemotherapy.

[15]  Patrick F. Kiser,et al.  Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  C. Rubod,et al.  A biomechanical model of the pelvic cavity: first steps , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[17]  Thomas J. Smith,et al.  Combination Pod-Intravaginal Ring Delivers Antiretroviral Agents for HIV Prophylaxis: Pharmacokinetic Evaluation in an Ovine Model , 2016, Antimicrobial Agents and Chemotherapy.

[18]  M. Turner,et al.  Evaluation of polycaprolactone matrices for the intravaginal delivery of metronidazole in the treatment of bacterial vaginosis , 2014, Journal of biomaterials applications.

[19]  K. Bash Review of vaginal pessaries. , 2000, Obstetrical & gynecological survey.

[20]  D. Katz,et al.  A vaginal fluid simulant. , 1999, Contraception.

[21]  Clare F. McCoy,et al.  Microbicide vaginal rings: Technological challenges and clinical development. , 2016, Advanced drug delivery reviews.

[22]  Clare F. McCoy,et al.  Vaginal rings for delivery of HIV microbicides , 2012, International journal of women's health.

[23]  Mathias Brieu,et al.  Biomechanical properties of prolapsed or non-prolapsed vaginal tissue: impact on genital prolapse surgery , 2010, International Urogynecology Journal.

[24]  Thomas J. Smith,et al.  An intravaginal ring for the simultaneous delivery of multiple drugs. , 2012, Journal of pharmaceutical sciences.

[25]  Jim R. Potvin,et al.  Maximum isometric finger pull forces , 2011 .

[26]  J. Benson Urogynecology and Reconstructive Pelvic Surgery , 2000 .

[27]  R. Vita,et al.  Mechanical Properties of Female Reproductive Organs and Supporting Connective Tissues: A Review of the Current State of Knowledge , 2016 .

[28]  M. Baum,et al.  Safety and pharmacokinetics of single, dual, and triple antiretroviral drug formulations delivered by pod-intravaginal rings designed for HIV-1 prevention: A Phase I trial , 2018, PLoS medicine.

[29]  P. Boyd,et al.  Intravaginal rings for continuous low‐dose administration of cervical ripening agents , 2018, International journal of pharmaceutics.